|
Volumn 99, Issue 3, 2010, Pages 295-296
|
Disparate risks and effects of pooled whole blood-derived vs. apheresis platelet production require an integral view on the blood supply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HLA ANTIBODY;
THROMBOCYTE CONCENTRATE;
APHERESIS;
BLOOD COMPONENT;
BLOOD DONOR;
BLOOD TRANSFUSION REACTION;
DISEASE TRANSMISSION;
ERYTHROCYTE;
HUMAN IMMUNODEFICIENCY VIRUS 1;
LETTER;
PRIORITY JOURNAL;
RISK ASSESSMENT;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPOIESIS;
BLOOD DONORS;
BLOOD PLATELETS;
HUMANS;
PLATELET ACTIVATION;
PLATELET TRANSFUSION;
PLATELETPHERESIS;
|
EID: 77956622268
PISSN: 00429007
EISSN: 14230410
Source Type: Journal
DOI: 10.1111/j.1423-0410.2010.01357.x Document Type: Letter |
Times cited : (3)
|
References (7)
|